Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07448584

Lok™ Suture Anchors Safety & Performance Trial

The aim of this study is to evaluate the performance and safety of Move-Up's lok™ system (lok™ suture anchors range and associated instrumentation). These devices will be evaluated at approximately 3, 6 and 12 months with 3 scoring criteria: Constant score, VAS pain score, and subjective shoulder value score (SSV). At the 6-month and 12-month post-operative visit, tendon healing, and the absence of recurrence of rupture or failure to heal in patients treated with lok™ anchors will also be analyzed.

The Sugaya score on ultrasound imaging will be used for this assessment. Adverse Events (AEs) and Serious Adverse Events (SAEs) will be assessed after the surgery and at each follow-up (1, 3, 6 and 12 months after the surgery).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alixan

Valence, Auvergne-Rhône-Alpes, 26300, France

Location status: Recruiting

Location contact

Arnaud Thevenin, Directeur Qualité Affaires Rég

CONTACT

[email protected]

33 660 883 369

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consent to participate in the study: oral and written.
  • Man or woman over 18 years old with bone maturity finished.
  • Presented with one of the following indications:
  • Rotator cuff lesion (tear or calcific tendinopathy) associated to a pathology of the long head of the biceps,
  • Gleno-humeral instability,
  • partial articular-sided tendon avulsion [PASTA] lesion.
  • MRI or arthrogram proving the rotator cuff lesion and long head of the biceps tendon injury, or the labrum injury, or PASTA injury.

Non inclusion Criteria:

  • Radiographic sign of fracture: glenoid or lesser tuberosity.
  • Major trauma to the shoulder joint.
  • Any active infection or avascular necrosis.
  • Inflammatory joint disease.
  • Moderate to severe degenerative glenohumeral arthropathy (Kellgren-Lawrence Grade 3 or 4).
  • Bone pathologies compromising anchorage (cystic changes, severe osteopenia).
  • Pathological conditions of soft tissues impairing suture fixation.
  • Known hypersensitivity to implant material (PEEK and carbon or Polyethylene).
  • Anterior ipsilateral surgeries performed on the joint space.
  • Physical conditions that would eliminate, or tend to eliminate, adequate anchoring support or delay healing.
  • Contraindications from the instructions for use of the medical devices used.
  • Conditions that would limit the subject's ability or willingness to restrict activities or follow instructions during the healing period.
  • Inability to complete questionnaires: language problems, who do not speak/read/understand French.
  • Pregnant or breastfeeding women.
  • Persons deprived of liberty or under guardianship.
  • Patients unable to undergo medical monitoring of the trial.
  • Psychiatric illnesses, cognitive disorders, or health problems that prevent informed consent.
  • Participation in another clinical trial.
  • Life expectancy of less than 12 months.
  • No health insurance.

Treatment and study plan

Rotator cuff lesions repair combined to a long head of biceps pathology

Procedure

Shoulder Gleno-humeral instability (Bankart lesion, SLAP lesion),

PASTA lesion

Procedure

partial articular-sided supraspinatus tendon avulsion (PASTA) lesions, treated with anchors specifically indicated for this repair

Shoulder instability repair

Procedure

Gleno-humeral instabilities (Bankart lesion, SLAP lesion)

Primary outcomes

  1. Constant score

    Time frame: From enrollment to the final follow up at 12 months

    The functional improvement related to the implantation of these devices will be at 3 months ± 7 days, 6 months ± 15 days and 12 months ± 15 days with the primary endpoint being the Constant score.

Secondary outcomes

  1. Visual Analog Scale (VAS)

    Time frame: From enrollment to the end of follow up at 12 months

    Evaluate the evolution of pain: This will be assessed using the Visual Analog Scale (VAS) for pain at 3 months ± 7 days, 6 months ± 15 days and 12 months ± 15 days.

  2. Adverse Events (AEs)

    Time frame: from enrollment to the final follow up at 12 months

    Evaluate the safety of the lok™ system: Adverse Events (AEs) related to the devices will be collected at any time from the start of inclusion until 12 months after surgery.

  3. Subjective Shoulder Value (SSV)

    Time frame: From enrollment to the final follow up at 12 months

    Evaluation of the patient's subjective value with the Subjective Shoulder Value (SSV) at 3 months ± 7 days, 6 months ± 15 days and 12 months ± 15 days.

Study contacts

Contact information is provided by the study sponsor or research team.

Manal OUBOUKHA, Clinical affairs manager

CONTACT

[email protected]

33 677 096 697

Sponsors and collaborators

Lead sponsor

Move Up SAS

Industry

Registry information

Official study title

Evaluation of the Safety and Performance of the Lok™ Suture Anchors Range and Associated Instrumentation - Multicenter Interventional and Single Blind Randomized Clinical Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 4, 2026
Registry last updated
Apr 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.